Short answer
Oscar Health, Inc. (OSCR) filed an 8-K current report with the SEC on September 16, 2026 reporting Item 7.01 (Regulation FD Disclosure). 2026 Medical Loss Ratio guidance improved to 81.0%–82.0%, 50 basis points better than prior expectations.
Oscar Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- 2026 Medical Loss Ratio guidance improved to 81.0%–82.0%, 50 basis points better than prior expectations
- 2026 Earnings from Operations guidance increased $100 million to $600 million–$800 million
- 2026 revenue guidance reaffirmed at $18.7 billion–$19.0 billion
- 2026 SG&A Expense Ratio guidance reaffirmed at 15.6%–16.1%
- Investor Day scheduled for September 16, 2026, with strategy and long-term financial targets ahead
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oscar Health, Inc. 8-K filings
Get the next OSCR 8-K as it lands
Follow OSCR for push alerts, or ask the research agent what this filing means.